Back
Milestone Pharmaceuticals Stock Price Chart
Sponsored
MIST
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
50
MIST
Milestone Pharmaceuticals
Last Price:
1.75
Seasonality Move:
44.98%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing slight selling pressure.
Milestone Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Buy |
20-day SMA: | 1.67 | Buy |
50-day SMA: | 1.67 | Buy |
200-day SMA: | 2.32 | Sell |
8-day EMA: | 1.67 | Buy |
20-day EMA: | 1.67 | Buy |
50-day EMA: | 1.69 | Buy |
200-day EMA: | 2.32 | Sell |
Milestone Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 55.04 | Buy |
Chaikin Money Flow: | -8497 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.62 - 1.76) | Buy |
Bollinger Bands (100): | (1.42 - 2.06) | Sell |
Milestone Pharmaceuticals Technical Analysis
Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Milestone Pharmaceuticals Stock
Is Milestone Pharmaceuticals Stock a Buy?
- Milestone Pharmaceuticals share price is 1.73 while MIST 8-day simple moving average is 1.64, which is a Buy signal.
- The stock price of MIST is 1.73 while Milestone Pharmaceuticals 20-day SMA is 1.67, which makes it a Buy.
- Milestone Pharmaceuticals 50-day simple moving average is 1.67 while MIST share price is 1.73, making it a Buy technically.
- MIST stock price is 1.73 and Milestone Pharmaceuticals 200-day simple moving average is 2.32, creating a Sell signal.
MIST Technical Analysis vs Fundamental Analysis
Sell
50
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy or a Sell?
-
Milestone Pharmaceuticals stock is rated a Sell
The current Milestone Pharmaceuticals [MIST] share price is $1.73. The Score for MIST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Milestone Pharmaceuticals Stock Info
Market Cap:
91.95M
Price in USD:
1.73
Share Volume:
146.82K
Milestone Pharmaceuticals 52-Week Range
52-Week High:
4.49
52-Week Low:
1.33
Sell
50
Milestone Pharmaceuticals (MIST)
is a Sell
Milestone Pharmaceuticals Share Price Forecast
-
What is the Milestone Pharmaceuticals stock price today?
The Milestone Pharmaceuticals stock price is 1.73 USD today. -
Will MIST stock go up or go down?
Milestone Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Milestone Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Milestone Pharmaceuticals is overvalued.
Is Milestone Pharmaceuticals Stock a Buy?
- Milestone Pharmaceuticals share price is 1.73 while MIST 8-day exponential moving average is 1.67, which is a Buy signal.
- The stock price of MIST is 1.73 while Milestone Pharmaceuticals 20-day EMA is 1.67, which makes it a Buy.
- Milestone Pharmaceuticals 50-day exponential moving average is 1.69 while MIST share price is 1.73, making it a Buy technically.
- MIST stock price is 1.73 and Milestone Pharmaceuticals 200-day simple moving average is 2.32, creating a Sell signal.
Fundamental Analysis of Milestone Pharmaceuticals
Is Milestone Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.18 per share, and a decrease next year of $0.38 per share.
Technical Analysis of Milestone Pharmaceuticals
Should I short Milestone Pharmaceuticals stock?
- MIST Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Milestone Pharmaceuticals is a Sell
- Milestone Pharmaceuticals Relative Strength Index (RSI) is 55.04, which suggest Milestone Pharmaceuticals is overbought
- The Bollinger Bands (25) for Milestone Pharmaceuticals is (1.62 - 1.76), which suggest Milestone Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Milestone Pharmaceuticals is (1.42 - 2.06), which suggest Milestone Pharmaceuticals is a Sell
* Milestone Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.